Nasdaq News

In trading on Friday, rental, leasing, & royalty shares were relative laggards, about flat on the day. Helping drag down the group were shares of Acacia Research, down about 2.1% and shares of San Juan Basin Royalty Trust down about 1.1% on the day.

In trading on Friday, the The Energy Select Sector SPDR— Fund ETF is outperforming other ETFs, up about 2.6% on the day. Components of that ETF showing particular strength include shares of Marathon Petroleum, up about 6.2% and shares of Apache, up about 5% on the day.

A compilation of the most active stocks on U.S. exchanges. For faster updates on individual market-movers, Eikon users please use search string "STXBZ US" and Thomson One users please search "RT/STXBZ US".

2020 is nearly half done, but you still have time to make adjustments to help you reduce the total tax you owe when it comes time to true up next April. After all, when all is said and done, what matters more than what you make is what you're able to keep to invest or spend on y

An Iranian cleric and judge accused of corruption in Tehran and also of human rights violations by activists was found dead on Friday at a hotel in the Romanian capital Bucharest, police said.

Fears of a second wave of coronavirus infections have increased demand for safe-haven assets, putting the U.S. dollar on track on Friday for its best weekly gain in a month.

Gamida Cell (GMDA) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.

Investors might want to bet on GenMark Diagnostics (GNMK), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.

NextEra Energy (NEE) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.

The following are today's upgrades for Validea's Price/Sales Investor model based on the published strategy of Kenneth Fisher. This value strategy rewards stocks with low P/S ratios, long-term profit growth, strong free cash flow and consistent profit margins.

The following are today's upgrades for Validea's Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap growth stocks with solid fundamentals and strong price performance.

The following are today's upgrades for Validea's P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relative to earnings growth that also possess strong balance sheets.

When it comes to retirement planning, young workers have it rough. Many are saving too little, and around one in three have taken a loan or withdrawal from their retirement accounts in response to COVID-19.  

By Brett Owens Successful dividend investing is simple, though not necessarily easy. There are nuances which trip up many investors (including most professionals!). These twists and turns create "yield alpha" opportunities for contrarian-minded income investors like us.

Zoom Video Communications (NASDAQ: ZM) reported fiscal first-quarter 2021 results earlier this month that delighted investors, who have had a fantastic ride since the videoconferencing specialist's initial public offering (IPO) in April 2019. Shares have increased more than six

(RTTNews) - U.S. airlines are stepping up enforcement of face covering policies, including banning passengers who do not wear face masks on flights amid the coronavirus pandemic.

Manchester City's Germany winger Leroy Sane has turned down the offer of a contract extension and will leave the club, manager Pep Guardiola said on Friday.

Health care stocks were mostly flat during premarket trading on Friday. The Vanguard Health Care ETF (VHT), the iShares Dow Jones US Healthcare (IYH), and the Health Care SPDR (XLV) were unchanged, while the iShares NASDAQ Biotechnology Index (IBB) was up 0.7%.

A compilation of the most active stocks on U.S. exchanges. For faster updates on individual market-movers, Eikon users please use search string "STXBZ US" and Thomson One users please search "RT/STXBZ US".

(RTTNews) - Biopharmaceutical company Ultragenyx Pharmaceutical Inc. said the U.S. Food and Drug Administration (FDA) approved its bone disease drug Crysvita (burosumab) in the form of injection for the treatment of tumor-induced osteomalacia (TIO) in patients aged two and older